Advertisement

Topics

Endpoint Research Company Profile

21:44 EST 10th December 2018 | BioPortfolio

Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I/II to IV clinical development services to pharmaceutical, biotechnology and medical device companies in most major therapeutic areas, with a strength in complex indications, particularly oncology and respiratory. Endpoint has been an international CRO since 1998 when we opened our office in the United Kingdom. We have continued to expand our geographic reach and service offerings by opening our US office and implementing full, Oracle Clinical-based clinical data management, Medical and Consulting services. Our head office is in Toronto, Canada with operational offices in Boston, Massachusetts and Edinburgh, Scotland. Endpoint provides full clinical trial services (study design, management, monitoring, data handling and statistical services) for clinical trials in North America and Europe, including Eastern Europe.

Location

24 New England Executive Park
Burlington
Massachusetts
01803-5203
United States of America

Contact

Phone: 1.866.900.1519
Fax: 1.866.901.1519
Email: info@endpointresearch.com


News Articles [277 Associated News Articles listed on BioPortfolio]

ICON Enhances Endpoint Adjudication Services

Will leverage AG Mednet's comprehensive electronic endpoint adjudication system

A New Endpoint in Prostate Cancer: Metastasis-Free Survival

With overall survival considered an impractical endpoint because survival is so long, metastasis-free survival has emerged as a new endpoint in prostate cancer trials. Medscape Medical News

endpoint Expands Global Footprint to Meet Growing Client Demand

endpoint Clinical, an industry leading global interactive response technology (IRT) company, has expanded their global footprint to provide more streamlined support for th...

Novartis’ brolucizumab meets primary endpoint in phase III nAMD trial

Brolucizumab met its primary endpoint of non-inferiority versus aflibercept in best corrected visual acuity (BCVA) and exhibited superiority in key retinal outcomes at year one (48 weeks). Secondary ...

#news #biotech Pfizer drops muscle-growth antibody after it misses phase 2 endpoint in DMD

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer drops muscle-growth antibody after it misses phase 2 endpoint in DMD ....

IGEL Positioned to Capitalize on Fast-Growing Demand for Linux at the Endpoint

SAN FRANCISCO, Aug. 27, 2018 /PRNewswire/ -- IGEL, a world leader in endpoint management software for the secure enterprise, today announced findings from the new Read more...

AstraZeneca’s Anifrolumab Fails to Meet the Primary Endpoint in its Phase 3 Trial in Systemic Lupus Erythematosus

AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from the TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-seve...

Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composit

Landmark Cardiovascular Risk Reduction Benefits Demonstrated in REDUCE-IT Are Largest of Any Major Cardiovascular Outcomes Study of a Drug Intended to Address Residual Cardiovascular Risk Remaining A...

Drugs and Medications [105 Associated Drugs and Medications listed on BioPortfolio]

La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]

Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]

ALCO-SAN INSTANT SKIN SANITIZER

Perindopril erbumine [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use perindopril erbumine safely and effectively. See full prescribing information for perindopril erbumine tablets.Perindopril Erbumine Ta...

Sunscreen [CRC (Cosmoceutical Research Center)]

SUNSCREEN SPF 28/30

Vionexus [Metrex Research]

VioNexus No Rinse Spray

PubMed Articles [742 Associated PubMed Articles listed on BioPortfolio]

Validation of the incremental shuttle walk test as a clinical endpoint in bronchiectasis.

There is a need for a validated clinical endpoint to assess response to therapies in bronchiectasis.

Extrapolation of in vitro structural alerts for mutagenicity to the in vivo endpoint.

As part of the hazard and risk assessment of chemicals in man, it is important to assess the ability of a chemical to induce mutations in vivo. Because of the commonalities in the molecular initiating...

Phase II trial design with growth modulation index as the primary endpoint.

Molecularly targeted, genomic-driven, and immunotherapy-based clinical trials continue to be advanced for the treatment of relapse or refractory cancer patients, where the growth modulation index (GMI...

ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.

Treatment-resistant schizophrenia (TRS) is common and debilitating. A subgroup of patients even has clozapine-resistant schizophrenia (CRS). We aimed to evaluate the efficacy and safety of electroconv...

Assessment of the Impact of an Endpoint Committee in the Ocular Hypertension Treatment Study.

To assess the impact of a masked Endpoint Committee on estimates of the incidence of primary open angle glaucoma (POAG), treatment efficacy and statistical power of the Ocular Hypertension Treatment S...

Clinical Trials [2342 Associated Clinical Trials listed on BioPortfolio]

Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy

Patients who have completed 3 years follow-up of the past Beijing Science and Technology Commission Research will receive another 2-years anti-viral therapy. Patients will be assessed at b...

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

This is a multi-center, prospective, international, randomized (1:1), open-label study with two parallel groups. This phase III study is planned to investigate the efficacy and safety of d...

Research Into the Quality of the Dying Phase

The aim of this study is to get insight in the quality of life at the end of life and quality of dying for patients died at the hospital in the department Groningen (the Netherlands). ...

Repeatability and Reproducibility of Skin Test Endpoint Titration

This study will examine the within-tester repeatability and between-tester reproducibility of skin test endpoint titrations performed in those with allergic sensitivities.

Risk Accessment Model for Ischemic Stroke Endpoint Events

The present study aims to develope a risk accessment model of ischemic stroke endpoint events combining multi-dimensional TCM indicators with modern medicine indicators. The proposed study...

Companies [1072 Associated Companies listed on BioPortfolio]

EndPoint Technologies

EndPoint Technologies is dedicated to providing comprehensive technology and business consulting services to life science organizations. Specializing in Medical Affairs in pharmac...

Endpoint Research

Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I/II to IV clinical development services to pharmaceutical, biotechnology and medical device compan...

endpoint

Endpoint provides clients with high-quality, authoritative advice on the clinical development of medicines. Endpoint's clients include multinational pharmaceutical companies, emerging biomedical ventu...

IGEL

IGEL delivers powerful unified endpoint management (UEM) software that is revolutionary in its simplicity and purpose-built for the enterprise. The company’s world-leading pr...

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announce...

More Information about "Endpoint Research" on BioPortfolio

We have published hundreds of Endpoint Research news stories on BioPortfolio along with dozens of Endpoint Research Clinical Trials and PubMed Articles about Endpoint Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endpoint Research Companies in our database. You can also find out about relevant Endpoint Research Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record